Karen Bräutigam - Concepedia

Author

Karen Bräutigam

Also Known As

Bräutigam, Karen, K Bräutigam, K H Bräutigam, K. -H. BRAUTIGAM, K. Bräutigam, K., Bräutigam, K.-H. Bräutigam, Karen Bräutigam, Karen Bräutigam

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Lübeck University Hospital Schleswig-Holstein RWTH Aachen University University of Cape Town Fraunhofer Institute for Molecular Biology and Applied Ecology

About

Karen Bräutigam is an author at University of Lübeck specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	799
2	Cell Biology	6	6	680
3	Health Sciences	2	2	49
4	Biomolecular Engineering	1	1	16
5	Cellular Physiology	1	1	54

Karen Bräutigam

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells Philip Rosenstiel, Massimo Claudio Fantini, Karen Bräutigam, Gastroenterology InflammationCytokineTranscriptional RegulationSignaling PathwayMucosal Immunology	2003	418
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer Dirk Bauerschlag, Nicolaì Maass, P Leonhardt, Journal of Translational Medicine	2015	130
Soluble tumor necrosis factor (TNF) receptor‐1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor‐β1 Georg H. Waetzig, Philip Rosenstiel, Alexander Arlt, The FASEB Journal ApoptosisImmunologyImmune RegulationCell DeathPathology	2004	111
A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion Andreas Till, Philip Rosenstiel, Karen Bräutigam, Journal of Cell Science Microbial PathogensInnate Immune SystemImmunologySignal RecognitionNod2 Function	2008	54
An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma Ivo Meinhold‐Heerlein, Dirk Bauerschlag, Yingyao Zhou, Clinical Cancer Research	2007	53
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles Dirk Bauerschlag, Ole Ammerpohl, Karen Bräutigam, Oncology	2011	52
PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer Frank Köster, Lisa Sauer, Friederike Hoellen, Oncology Letters Prognostic BiomarkersTumoral PathologyCervical CancerRadiation TherapyStronger Psmd9 Expression	2020	39
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR Verena von Felbert, Dirk Bauerschlag, Nicolaì Maass, Journal of Cancer Research and Clinical Oncology Specific Photoimmunotheranostics AgentPhotocarcinogenesisImmunologySkin Cancer CellsPhotosensitizers	2016	36
Reduced hemopexin levels in peritoneal fluid of patients with endometriosis Monika Wölfler, Ivo Meinhold‐Heerlein, Corinna Henkel, Fertility and Sterility MedicineHemopexin LevelsGynecologyReproductive Endocrinology	2013	34
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand Manal Amoury, Dirk Bauerschlag, Felix Zeppernick, Oncotarget Breast OncologyNanotherapeuticsImmunologyImmunotherapeuticsTnbc Cells	2016	33

Page 1